asthma inhaler In patients with COPD, tiotropium/olodaterol was associated with a lower risk for escalation to triple therapy or the development of adverse outcomes compared with LABA/ICS. After ...
Two strategies are commonly used as maintenance treatment for patients with moderate or severe chronic obstructive pulmonary disease (COPD): (1) an inhaled corticosteroid + long-acting beta-agonist ...
Please provide your email address to receive an email when new articles are posted on . Inhalers with a long-acting muscarinic antagonist and a long-acting beta agonist (LABA) resulted in “better ...
Please provide your email address to receive an email when new articles are posted on . Perioperative combination therapy using a long-acting muscarinic antagonist and long-acting beta agonist may be ...
"Clinicians are conscientious people, and the message for them from our research is to make sure that they start medications promptly in patients with COPD after an acute hospital stay…On admission, ...
New trial analysis shows COPD treatment withdrawal, including LAMA and ICS discontinuation, can trigger early exacerbation ...
LA JOLLA, Calif., October 07, 2025--(BUSINESS WIRE)--AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic ...
An overview of the medication classes available for the treatment of chronic obstructive pulmonary disease and recommendations for how to utilize and in whom. Transcript: Neil B. Minkoff, MD: Let’s ...
AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic respiratory diseases, today announced the closing of a $21 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback